 |
Ob/gyns now have more options than ever to ward off adhesions and achieve hemostasis.
Apr 15, 2008
By:
Matthew W. Guile, MD, Robert E. Bristow, MD
|
Adhesion barriers and controlling excess bleeding during pelvic surgery are easier than ever—thanks to biotechnology advances.  A laparoscopic procedure is an option for many women with endometrial cancer. Here, two expert gynecologic oncologists tell you what the surgery involves and how to select patients for referral.
Feb 1, 2007
By:
Pedro T. Ramirez, MD, Brian M. Slomovitz, MD
|
A laparoscopic procedure is an option for many women with endometrial cancer. Here, two expert gynecologic oncologists tell you what the surgery involves and how to select patients for referral. Nov 1, 2006
By:
Michael L. McDaniel, MD, Andrew Berchuck, MD
|
How many times has a patient said, "Oh, by the way, doctor..." just as you're leaving the exam room? This column will help you quickly triage those seemingly offhand yet clinically significant encounters. Will biological warfare revolutionize the battle against gynecologic cancers? Two experts share the latest molecular tactics using "special" agents. Lethal weapons like Herceptin can throw up some roadblocks, even when they can't always destroy a tumor.
Oct 1, 2006
By:
Angeles Alvarez Secord, MD, Andrew Berchuck, MD
|
Will biological warfare revolutionize the battle against gynecologic cancers? Two experts share the latest molecular tactics using "special" agents. Lethal weapons like Herceptin can throw up some roadblocks, even when they can't always destroy a tumor. Though most of these common tumors are benign, 0.5% of patients undergoing hysterectomy for presumed fibroids will be found to have a leiomyosarcoma, which usually kills within 5 years if it spreads outside the uterus. And five patients' leiomyosarcomas weren't diagnosed until after UAE.
Aug 1, 2006
By:
Robert L. Giuntoli, II, MD, Robert E. Bristow, MD
|
Though most of these common tumors are benign, 0.5% of patients undergoing hysterectomy for presumed fibroids will be found to have a leiomyosarcoma, which usually kills within 5 years if it spreads outside the uterus. And five patients' leiomyosarcomas weren't diagnosed until after UAE. A leading expert helps you educate yourself—and your patients—about putting combined HPV-Pap testing into practice. Patient education should stress how common HPV is and explain the high level of reassurance testing negative on both tests affords.
Jun 1, 2006
By:
J. Thomas Cox, MD
|
A leading expert helps you educate yourself—and your patients—about putting combined HPV-Pap testing into practice. Patient education should stress how common HPV is and explain the high level of reassurance testing negative on both tests affords. These experts urge meticulous wound closure, as they share their own protocols and tips and review your incision options for complicated open pelvic surgery—especially in obese women.
Jun 1, 2006
By:
Donald G. Gallup, MD, James J. Burke II, MD, Snehal M. Bhoola, MD
|
These experts urge meticulous wound closure, as they share their own protocols and tips and review your incision options for complicated open pelvic surgery—especially in obese women. If there's really been such a sea change in how and when to screen for cervical cancer, when are clinicians going to take the plunge and start applying new recommendations? An expert comes to the rescue by sifting through the new ACS and ACOG guidelines, to help you put them into practice.
Apr 1, 2006
By:
J. Thomas Cox, MD
|
If there's really been such a sea change in how and when to screen for cervical cancer, when are clinicians going to take the plunge and start applying new recommendations? An expert comes to the rescue by sifting through the new ACS and ACOG guidelines, to help you put them into practice. Mar 1, 2006
By:
John O. Schorge, MD, Gautam G. Rao, MD
|
In recent years, cisplatin-based chemotherapy given concurrent with radiation has emerged as the new standard of care for treating locally advanced cervical cancer.
|
| 
